Abstract

This study investigated the therapeutic effects of renal denervation on cardiac systolic function after myocardial infarction (MI) in rats and the mechanism involved. Fifty male SD rats were randomly assigned to the sham group (n = 15), the MI group (n = 20), and the MI plus renal denervation group (n = 15). MI was established through thoracotomic ligation of the anterior descending artery. Renal denervation was achieved by laparotomic stripping of the renal arterial adventitial sympathetic nerve, approximately 3 mm from the abdominal aorta. Left ventricular function and hemodynamics were measured several weeks following MI. The left ventricular systolic function of the MI group was significantly reduced and the systolic blood pressure (SBP) remarkably declined. In rats with MI treated with renal denervation, the left ventricular ejection fraction (EF), fractional shortening (FS) and SBP markedly improved compared with the MI group. However, heart rate and fibrosis decreased significantly. These findings suggest that renal denervation has therapeutic effects on post-MI cardiac dysfunction. These effects are associated with increased left ventricular ejection fraction (LVEF) and SBP, as well as reduced heart rate and fibrosis. This may represent a new approach to the treatment of post-MI remodeling and subsequent heart failure.

Highlights

  • Acute myocardial infarction (MI) results in low blood pressure and loss of myocardial tissue

  • There was no significant difference in weight, blood pressure, heart rate and echocardiographic parameters for each group at baseline before MI (See Table 1)

  • Fibrosis area was reduced in the MI plus renal denervation (RD) compared with the MI group (Fig. 3D)

Read more

Summary

Introduction

Acute myocardial infarction (MI) results in low blood pressure and loss of myocardial tissue This leads to the activation of a series of neurohormonal f­actors, such as the sympathetic nervous system (SNS), the renin-­angiotensin-aldosterone system (RAAS) and endothelin. These factors increase the heart rate, myocardial contractility and vasoconstriction to help maintain hemodynamic stability. Increasing data have revealed that blockade of the SNS and RAAS has therapeutic effects on heart failure[4,5] This suggests that RD may have great potential in the treatment of heart failure and diseases related to chronic sympathetic activation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call